The use of thromboprophylaxis in Danish surgical departments: The results of the fifth survey;Anvendelsen af tromboseprofylakse på kirurgiske afdelinger i Danmark: Resultatet af den femte enqueteundersøgelse

Ugeskrift for Laeger

Volumn 167, Issue 1, 2005, Pages 43-46

  Rasmussen, Hans Worten Schnack ^a   Chauhan, Priya A ^a   Wille Jørgensen, Peer A ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; DENMARK; EVIDENCE BASED MEDICINE; FEMALE; FIRST AID; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; QUESTIONNAIRE; SURGICAL PATIENT; SURGICAL WARD; THROMBOEMBOLISM; THROMBOSIS; TREATMENT OUTCOME;

ASPIRIN; DENMARK; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; PRACTICE GUIDELINES; QUESTIONNAIRES; THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 11444250329     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Siragusa S, Beltrametti C, Barone M et al. Clinical course and incidence of post-thrombophlebitic syndrome after profound asymptomatic deep vein thrombosis. Results of a transverse epidemiologic study. Minerva Cardioangiol 1997;45:57-66.
2. Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Chest 2001;119(suppl 1):132S-75S.
3. Wille-Jorgensen P. Prophylaxis of postoperative thromboembolism. Dan Med Bull 1991;38:203-28.
4. Wille-Jørgensen P, Hauch O. Thromboliprofylakse i Danmark. Ugeskr Læger 1987;149:1811-4.
5. Sørensen SH, Sørensen JL, Rasmussen HM et al. Principper for tromboseprofylakse på kirurgiske afdelinger i Danmark. Ugeskr Læger 1997;159:1261-4.
6. Lausen IM, Rasmussen HM, Wille-Jørgensen PA. Forebyggelse af postoperativ tromboemboli i Danmark. Ugeskr Læger 1992;154:3763-6.
7. Wille-Jørgensen P, Jørgensen T. Thromboseprofylakse i Danmark. Ugeskr Læger 1982;144:1600-2.
8. Burns PJ, Wilsom RG, Cunningham C. Venous thromboembolism prophylaxis used by consultant general surgeons in Scotland. J R Coll Surg Edinb 2001;46:329-33.
9. Caprini JA, Arcelus J, Sehgal LR et al. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States. Int Angiol 2002;21:78-85.
10. Williams EV, Williams RS, Hughes JL et al. Prevention of venous thromboembolism in Wales: results of a survey among general surgeons. Postgrad Med J 2002;78:88-91.
11. Walker N, Rodgers A, Gray H. Changing patterns of pharmacological thromboprophylaxis use by orthopaedic surgeons in New Zealand. ANZ J Surg 2002;72:335-8.
12. Wille-Jorgensen P, Hauch O, Dimo B et al. Prophylaxis of deep venous thrombosis after acute abdominal operation. Surg Gynecol Obstet 1991;172:44-8.
13. Filtenborg TT, Rasmussen MS, Wille-Jorgensen P. Survey of the use of thromboprophylaxis in laparoscopic surgery in Denmark. Br J Surg 2001;88:1413-6.
14. Mismetti P, Laporte S, Darmon JY et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 2001;88:913-30.
15. Nielsen JD, Holm-Nielsen A, Jespersen J et al. The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy-a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol 2000;34:194-8.
16. Rauck RL. The anticoagulated patient. Reg Anesth 1996;21(suppl 6):51-6.
17. Breivik H, Brosstad F. Bleeding complications of spinal and epidural analgesia. Tidsskr Nor Laegeforen 1998;118:210-1.
18. Hull RD, Pineo GF, Stein PD et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 2001;135:858-69.
19. Bergqvist D, Agnelli G, Cohen AT et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975-80.
20. Rasmussen MS. Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis. Cancer Treat Rev 2002;28:141-4.